Karo Bio Post Coup

Now that a shareholder group has swept out the entire six-person board at Karo Bio AB (SSE:KARO), the question is what happens to the strategy and management at the metabolic play. At this point, "stay the course" seems to be the answer.

The move was primarily an effort to replace former chairman Bo Hakansson, according to Lars Magnusson, a shareholder who appeared at the annual shareholder meeting as a representative for Jan Lundberg, the architect of the overhaul...